Mable Therapy has secured funding
Mable Therapy has raised funds from Gresham House Ventures, a growth equity investor specializing in digitally driven businesses, to further build out its proprietary technology platform, as well as invest in sales and marketing capabilities, helping take the business to its next stage of growth.
Mable Therapy is the UK’s leading digital platform for children’s speech and language therapy and counselling services. Using cutting-edge, gamified technology, Mable Therapy’s interactive platform captivates children and young people from the moment they start their session. The platform uses creative resources, games and tools to reduce anxiety and make therapy engaging and fun.
Oaklins Cavendish, based in the UK, advised Mable Therapy on its investment from Gresham House Ventures.
Contáctese con el equipo de la transacción
Transacciones relacionadas
Den Berk Délice accelerates growth through strategic partnership
Den Berk Délice, a leading Belgian grower of specialty tomatoes, has entered a strategic partnership with Egeria, an independent investment firm, to realize its next growth phase.
Conozca másXiel Limited has been acquired by MIS Healthcare
MIS Healthcare, a leading distributor in medical imaging, has successfully acquired Xiel Limited. This strategic acquisition merges MIS Healthcare’s extensive radiotherapy portfolio with Xiel’s specialized expertise in nuclear medicine, radiotherapy and diagnostic radiology. The merger strengthens both companies’ positions in the rapidly growing fields of oncology and nuclear medicine, promising to deliver exceptional value to the healthcare community in the UK and Ireland.
Conozca másMicrofinanciera Fundeser has been sold to Grupo Financiero Atlántida
Incofin has successfully exited its investment in Microfinanciera Fundeser in Nicaragua through two of its funds: Rural Impulse Fund II (RIF II) and agRIF. It has sold 100% of its stake in Microfinanciera Fundeser to Grupo Financiero Atlántida through its subsidiary, Inversiones Tres Lagos.
Conozca más